Brexit: what does this mean for cell and gene therapy regulation?

In by

Date and Time to be Confirmed Shortly

Presenter: Dr Jacqueline Barry


Since article 50 was triggered on March 29 2017 starting the formal process of the UK exiting the European Union, the Cell and Gene Therapy Catapult have been trying to understand what this means for regulation in the cell and gene therapy industry. Our specialist team have been working to try and understand the implications of the EU Referendum outcome, as well as the challenges and opportunities that it might present the cell and gene therapy industry.

Join this free webinar to hear Dr Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy Catapult discuss what we know so far about the regulation of cell and gene therapy products outside the European Union, some of the challenges and opportunities that it will present the cell and gene therapy industry and what we might expect for regulation of cell and gene therapies in the future.

This engaging webinar will feature:

  • Practicalities of the UK leaving the European Union - what do we know so far?
  • Challenges facing the cell and gene therapy industry as a result of the UK leaving the European Union
  • Opportunities for the cell and gene therapy industry
  • What might the future look like for cell and gene therapy regulation?

Dr Jacqueline Barry

Chief Clinical Officer, Cell and Gene Therapy Catapult
Jacqueline is Chief Clinical Officer at Cell and Gene Therapy Catapult. Prior to this Jacqueline worked at the Scottish National Blood Transfusion Service in a number of senior regulatory and quality positions, the responsibility for which included designing the regulatory strategy for the Cellular Therapies developed by the Blood Transfusion Service, acting as Responsible Person for Blood and Qualified Person for medicinal product release. Before that she held a number of post-Doctoral academic posts at the University of Edinburgh studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell based medicinal products and therapies.
 
Register for Free
 
 
By registering for this webinar you are also signing up as a member of Cell & Gene Therapy Insights and agree to be contacted by Cell & Gene Therapy Insights' sponsors. We will email you a username and password so you can read all our open access content.